Turpaz Industries (TRPZ) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
3 Nov, 2026Executive summary
Q1 revenue was $83.641m, up 38.6% YoY, with 9.0% organic growth; adjusted EBITDA increased 42.4% to $19.389m, and net income rose 104.5% to $11.065m.
Phoenix and Romessence acquisitions lifted the annualized sales run rate to $380m and expanded flavor and fragrance capabilities.
Financial highlights
Gross profit rose 48.9% to $35.029m; gross margin increased to 41.9% from 39.0%.
Operating income rose 33.6% to $12.874m; reported operating margin was 15.4% vs. 16.0%, while adjusted operating margin was 16.0% in both periods.
Non-GAAP net income rose 48.8% to $11.721m, or 14.0% of sales; reported net income was $11.065m, or 13.2% of sales.
Basic and diluted EPS was $0.09 vs. $0.04; net finance results included $1.050m income vs. $2.487m expense in Q1 2025.
Outlook and guidance
Strategic goal is to double sales every four years or less; the $380m sales run rate and active M&A pipeline support the growth strategy.
Phoenix integration and Klabin-Turpaz are expected to generate $2m in synergies over coming quarters, including US operating efficiencies and cross-selling.
Specialty Fine Ingredients product-mix initiatives are expected to support profitability; estimates remain subject to execution and market risks.
Latest events from Turpaz Industries
- Record Q1 growth was led by Taste and acquisitions, while Specialty Fine Ingredients weakened.TRPZ
Q1 2024 - Acquisitions and Taste/Scent growth lifted record results despite Specialty Fine Ingredients weakness.TRPZ
Q2 2024 - Acquisition-led growth lifted sales and adjusted EBITDA as Specialty Fine Ingredients weakened.TRPZ
Q3 2024 - FY24 sales rose 48.4%, with adjusted EBITDA up 54.8%.TRPZ
Q4 2024 - Record Q1 sales of $60.4M and adjusted EBITDA of $13.6M reflected organic growth and acquisitions.TRPZ
Q1 2025 - Q2 sales grew 35.6%, with 14.2% organic growth and a 23.1% adjusted EBITDA margin.TRPZ
Q2 2025 - Q3 sales rose 57.4% as organic growth and acquisitions lifted adjusted EBITDA 55.1%.TRPZ
Q3 2025 - Revenue rose 45.6% in 2025 as adjusted EBITDA margin reached 23.1%.TRPZ
Q4 2025 - Acquisitions and organic growth drove record sales, while integration and production ramp-up shape the outlook.TRPZ
Q2 2026